However, if you also meet criteria for obesity (BMI 30+) or overweight with comorbidities (BMI 27+), you may qualify for coverage under weight management indications
It works similarly to semaglutide by signaling our brain to tell us we are full, slows down the digestive process to keep us fuller longer, and helps to lower blood sugar levels
This date appears on the vial label and typically reflects a 30-day window from the compounding date
She discussed her teams findings and the trade-offs involved in starting any new drug, no matter how miraculous it might sound
This medication is not approved by the FDA for weight loss
Excess visceral adiposity is strongly associated with: Type 2 diabetes mellitus and insulin resistance Cardiovascular disease and hypertension Non-alcoholic fatty liver disease (NAFLD) Certain cancers, including colorectal and breast cancer Metabolic syndrome According to NHS guidance, waist circumference measurements exceeding 94 cm in men and 80 cm in women (for white European populations) indicate increased metabolic risk, largely driven by visceral fat accumulation